25 August 2020 - Deborah Wilkes
Archived
Private-equity firm Blackstone is acquiring Takeda’s Japanese OTC business, Takeda Consumer Healthcare Company (TCHC), in a deal worth around JPY242 billion (USD2.29 billion).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.